Temecula
Temecula, California 92591
We've found
1 trials
at this facility
PTSD Clinical Trial
Updated: 12/31/1969
A 40-week Study to Evaluate TNX-102 SL 5.6 mg Taken Daily at Bedtime in Patients With PTSD
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
![](https://www.clinicaltrialsgps.com/wp-content/themes/GPS/media//img/tooltip-arrow.png)